The Mayo Clinic has experience treating patients with malignant mesothelioma and has a deep understanding of how challenging a mesothelioma diagnosis can be for patients and loved ones.
The Mayo Clinic’s mesothelioma treatment plan depends on the patient. Their physicians understand that many cases are diagnosed in the advanced stages, in which case patients may want to focus solely on palliative care to improve their symptoms and live the highest quality of life possible. For those that are willing to undergo any treatment, the Mayo Clinic is experienced with mesothelioma surgery (including pleurodesis, pleurectomy, extrapleural pneumonectomy and surgery with HIPEC), chemotherapy, radiation therapy, immunotherapy and targeted therapy.
Such treatments may occur within the Mayo Clinic Thoracic Surgery Division, which was founded in 1915. This division is currently one of the largest in the country. The staff includes five board-certified general chest surgeons who provide comprehensive diagnosis and surgical care to cancer patients with diseases of the chest wall and mediastinum, diaphragm, esophagus, lungs and trachea. Pathologists, oncologists, diagnostic specialists and surgeons assist in the diagnosis and treatment of mesothelioma.
Patients may have the option to forgo standard mesothelioma treatments and try alternative options with guidance from their Mayo Clinic physician. Experimental treatments are available to eligible patients through clinical trials conducted through the Mayo Clinic.
The Mayo Clinic has multiple locations with their Arizona, Minnesota and Florida campus locations, offering care to patients across the United States. The non-profit institution that treats more than half a million patients annually. The staff includes more than 3,300 physicians, scientists, and researchers in addition to 46,000 allied health-care workers at Mayo Clinic sites throughout the nation.
- Targeted therapy
- American Nurses Credentialing Center Magnet Recognized
- National Cancer Institute Comprehensive Cancer Center designation
- U.S. News Best Hospitals Honor Roll
Mesothelioma Clinical Trials at Mayo Clinic Cancer Center
The following clinical trials are in progress or actively recruiting participants at Mayo Clinic Cancer Center:
Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma
Last Updated: September 9, 2019
Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma
Conditions: Mesothelioma, Lung Neoplasms
Last Updated: August 30, 2019
Ph 2/3 Study in Subjects With MPM w/Low ASS 1 Expression to Assess ADI-PEG 20 With Pemetrexed and Cisplatin
Last Updated: August 20, 2019
Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin
Conditions: Mesothelioma, Lung Neoplasms, Neoplasms
Last Updated: June 10, 2019
- Mesothelioma Doctors
- Cancer Centers
- Treatment Near You
- Experimental Treatments
- Alternative Treatments
- Clinical Trials
- Caregiver Resources
- Treatment Costs